Zacks: Analysts Expect Omega Healthcare Investors Inc (OHI) Will Post Earnings of $0.74 Per Share

Equities research analysts expect Omega Healthcare Investors Inc (NYSE:OHI) to report $0.74 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Omega Healthcare Investors’ earnings, with estimates ranging from $0.70 to $0.77. Omega Healthcare Investors posted earnings of $0.76 per share in the same quarter last year, which would suggest a negative year over year growth rate of 2.6%. The firm is expected to announce its next earnings report on Friday, August 2nd.

According to Zacks, analysts expect that Omega Healthcare Investors will report full year earnings of $3.05 per share for the current fiscal year, with EPS estimates ranging from $2.99 to $3.09. For the next financial year, analysts anticipate that the firm will report earnings of $3.24 per share, with EPS estimates ranging from $3.17 to $3.26. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover Omega Healthcare Investors.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Tuesday, May 7th. The real estate investment trust reported $0.34 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.37). The company had revenue of $188.20 million for the quarter, compared to analyst estimates of $190.54 million. Omega Healthcare Investors had a return on equity of 7.02% and a net margin of 30.17%. The business’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter last year, the business posted $0.78 earnings per share.

OHI has been the topic of a number of recent research reports. Zacks Investment Research downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Tuesday, April 16th. Scotiabank initiated coverage on shares of Omega Healthcare Investors in a report on Thursday, February 7th. They issued a “sector perform” rating and a $39.37 price objective on the stock. Stifel Nicolaus downgraded shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $39.00 price objective on the stock. in a report on Thursday, February 7th. Finally, ValuEngine downgraded shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Wednesday, April 3rd. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $37.05.

In related news, Director Ben W. Perks sold 3,000 shares of the business’s stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $37.64, for a total transaction of $112,920.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Daniel J. Booth sold 40,000 shares of the business’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $36.51, for a total transaction of $1,460,400.00. Following the transaction, the chief operating officer now owns 187,206 shares in the company, valued at $6,834,891.06. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 75,788 shares of company stock worth $2,810,176. 1.65% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently modified their holdings of OHI. Marshall Wace LLP bought a new position in Omega Healthcare Investors during the first quarter worth $3,095,000. Princeton Global Asset Management LLC bought a new position in Omega Healthcare Investors during the first quarter worth $134,000. B. Riley Wealth Management Inc. bought a new position in Omega Healthcare Investors during the first quarter worth $196,000. Cleararc Capital Inc. bought a new position in Omega Healthcare Investors during the first quarter worth $200,000. Finally, Metropolitan Life Insurance Co NY boosted its position in Omega Healthcare Investors by 1.3% during the first quarter. Metropolitan Life Insurance Co NY now owns 69,814 shares of the real estate investment trust’s stock worth $2,663,000 after purchasing an additional 912 shares during the period. Institutional investors and hedge funds own 69.32% of the company’s stock.

Shares of NYSE OHI traded up $0.08 during midday trading on Friday, reaching $35.56. The company’s stock had a trading volume of 82,264 shares, compared to its average volume of 1,651,512. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 1.16. Omega Healthcare Investors has a fifty-two week low of $28.65 and a fifty-two week high of $40.30. The company has a market capitalization of $7.31 billion, a PE ratio of 11.67, a price-to-earnings-growth ratio of 4.62 and a beta of 0.46.

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Tuesday, April 30th were issued a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, April 29th. This represents a $2.64 dividend on an annualized basis and a yield of 7.42%. Omega Healthcare Investors’s payout ratio is 86.84%.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

See Also: What impact do institutional investors have on markets?

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.